AG真人官方

The Vanguard Group filed Amendment No. 10 to Schedule 13G on 29 Jul 2025, disclosing its passive ownership of Apple Inc. (AAPL) as of 30 Jun 2025.

Vanguard beneficially owns 1,415,826,462 Apple common shares, representing 9.47 % of the outstanding class. It reports 0 shares with sole voting power and 19,800,347 shares with shared voting power, while holding sole dispositive power over 1,343,278,627 shares and shared dispositive power over 72,547,835 shares.

The firm qualifies as an investment adviser under Rule 13d-1(b)(1)(ii)(E) and certifies the holdings were acquired in the ordinary course of business, with no intent to influence Apple鈥檚 control. No additional material transactions or strategic intentions are noted.

On 24 Jul 2025 Kestra Medical Technologies (KMTS) director Raymond W. Cohen filed Form 4 disclosing the automatic conversion and acquisition of 12,994 restricted common shares. The shares arose from previously granted Class A units of West Affum Holdings that converted in conjunction with the company鈥檚 IPO; therefore, no cash consideration was paid (transaction code 鈥淎鈥�). After the event, Cohen鈥檚 beneficial ownership stands at 12,994 KMTS shares held directly.

The award vests in three tranches: 4,331 shares vested immediately on 24 Jul 2025; an additional 4,331 will vest on 24 Jul 2026; and the remaining 4,332 will vest on 24 Jul 2027. The filing shows no open-market purchases, sales, option activity, or derivative positions, and it contains no financial performance metrics.

While the transaction modestly increases insider alignment, the share amount is relatively small and is unlikely to be market-moving by itself.

Form 4/A overview: Clover Health Investments Corp. (ticker: CLOV) filed an amended Form 4 covering CEO Conrad Wai鈥檚 recent equity transactions.

• Equity grant: On 09/13/2024, Wai earned 379,866 restricted stock units (RSUs) linked to a performance-based award granted 10/31/2023. Half (189,933 shares) vested and settled the same day at $0 cost; the remaining half will vest on 10/31/2025, subject to continued employment.
• Share sale: On 07/08/2025, Wai sold 15,203 Class A shares under a Rule 10b5-1 trading plan adopted 03/03/2025. The weighted-average sale price was $3.26 with trades executed between $3.25 and $3.27.
• Post-transaction holdings: After these activities, Wai directly owns 1,699,767 Class A shares and indirectly (via family trust) 1,613,498 shares.
• Purpose of amendment: The filing corrects the total number of RSUs achieved in the October 2023 performance grant.

No derivative securities were reported, and all transactions were executed either at no cost (RSU settlement) or under a pre-established 10b5-1 plan. The filing bears Wai鈥檚 signature via attorney-in-fact dated 07/10/2025.

Form 4 filing for Clover Health Investments Corp. (CLOV) discloses three transactions by Jamie L. Reynoso, CEO 鈥� Medicare Advantage, on July 3 and July 7, 2025.

• Dispositions: 19,789 Class A shares sold on 7/3/25 at a weighted-average price of $2.58; 2,012 shares sold on 7/7/25 at $2.85. Both sales executed under a Rule 10b5-1 plan adopted 3/13/25.
• Withholding for taxes: 8,706 shares automatically withheld on 7/3/25 at $2.56 to satisfy tax obligations upon RSU vesting.
• Post-transaction ownership: Reynoso continues to hold 3,297,821 Class A shares directly.
• The RSU award that triggered the tax withholding vests quarterly through 1/3/27, subject to continued service.

No derivative security activity was reported. The transactions represent roughly 0.66 % of Reynoso鈥檚 stated post-filing stake, indicating a modest reduction in ownership.

Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) filed a Form 144 indicating that insider Yury Gryzlov intends to sell 2,000 common shares through Morgan Stanley Smith Barney LLC. The shares are valued at $24,660 and are expected to be sold on 07/08/2025. Gryzlov acquired the shares as restricted stock on 03/13/2021. The company has 84,547,653 shares outstanding, so the planned sale represents only about 0.002 % of the float. During the past three months, the same insider sold an additional 4,737 shares for $59,151.34. No other financial or operational data is provided in this notice.

Clover Health Investments, Corp. (CLOV) has filed a Form 144 indicating a proposed sale of insider shares.

• Shares to be sold: 2,012 common shares
• Estimated market value: $5,150.72
• Broker: Morgan Stanley Smith Barney LLC, New York
• Planned execution date: 07/07/2025 on NASDAQ
• Total shares outstanding: 416,541,578 (sale equals ~0.0005% of float)

The filing also lists recent 10b5-1 sales by the same insider, Jamie Reynoso, totaling 40,239 shares for gross proceeds of $109,504.30 across two transactions on 06/17/2025 and 07/03/2025.

Because the proposed sale is immaterial relative to the company鈥檚 share count, the market impact is expected to be minor; however, continual insider selling can be perceived negatively by some investors.

Clover Health Investments (CLOV) 鈥� Form 4 insider filing: CEO and Director Andrew Toy reported an automatic share disposition on 07/01/2025 related to the vesting of previously granted RSUs. A total of 308,950 Class A common shares were withheld to satisfy tax obligations (transaction code 鈥淔鈥�) at a reference price of $2.75. Following the withholding, Toy鈥檚 direct beneficial ownership stands at 10,560,047 shares. The RSU award, originally granted on 01/01/2023 and reported on 01/04/2023, vests quarterly in equal 6.25% installments through 01/01/2027, contingent upon continued service.

The filing reflects a routine, non-open-market administrative transaction rather than an elective sale, and does not indicate a change in Toy鈥檚 long-term ownership intent. No derivative securities or additional open-market trades were reported.